Kovai Medical Center & Hospital Ltd. AI Stock Analysis
Want to see IN:KOVAI full AI Analyst Report?
Kovai Medical Center & Hospital Ltd. (KOVAI) AI Stock Analysis
Kovai Medical Center & Hospital Ltd.
(NSE:KOVAI)
The company's strong financial foundation, characterized by solid revenue growth, high-quality earnings, and a conservative balance sheet, is the primary driver of the score. Positive technical trends provide additional support. The moderately high valuation and negligible dividend yield temper the overall assessment.
Kovai Medical Center & Hospital Ltd. (KOVAI) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 87.95B
- Dividend Yield
- 0.23%
- Average Volume (3M)
- 637
- Price to Earnings (P/E)
- 26.1
- Beta (1Y)
- 0.41
- Revenue Growth
- 16.69%
- EPS Growth
- 18.45%
- Country
- India
- Employees
- 6,885
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Kovai Medical Center & Hospital Ltd. Business Overview & Revenue Model
Company Description
Kovai Medical Center and Hospital Limited (KMCH) is a prominent Indian entity offering a diverse range of hospital services. Its operations are segmented into two core areas: healthcare provision and education. Within its robust healthcare division,...
How the Company Makes Money
KOVAI primarily makes money by delivering hospital-based healthcare services and charging patients (or their insurers/employers/government schemes, where applicable) for medical treatment and related services. Key revenue streams typically include: (...
Kovai Medical Center & Hospital Ltd. Financial Statement Overview
Summary
Strong overall financial health with robust revenue growth (11%), a healthy 15.4% net margin, and a conservative balance sheet (debt-to-equity of 0.31). Operating cash flow of ₹3,540 million exceeds net income, indicating high-quality earnings, though declining gross margins are a minor concern.
Income Statement
78PositiveBalance Sheet
88Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.24B | 15.86B | 13.71B | 12.20B | 10.19B | 9.04B |
| Gross Profit | 7.88B | 5.01B | 4.63B | 6.23B | 7.36B | 6.48B |
| EBITDA | 5.18B | 4.67B | 4.08B | 3.62B | 2.88B | 2.72B |
| Net Income | 2.71B | 2.44B | 2.09B | 1.80B | 1.16B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 22.24B | 20.66B | 18.00B | 14.38B | 14.42B | 13.43B |
| Cash, Cash Equivalents and Short-Term Investments | 3.75B | 3.47B | 2.71B | 2.08B | 2.47B | 1.96B |
| Total Debt | 3.77B | 4.03B | 4.15B | 3.10B | 5.11B | 5.50B |
| Total Liabilities | 7.73B | 7.47B | 7.14B | 5.50B | 7.23B | 7.33B |
| Stockholders Equity | 14.52B | 13.19B | 10.86B | 8.89B | 7.19B | 6.09B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.02B | -294.49M | 2.06B | 1.36B | 1.63B |
| Operating Cash Flow | 0 | 3.54B | 3.24B | 3.44B | 2.63B | 2.62B |
| Investing Cash Flow | 0 | -2.51B | -3.52B | -1.38B | -1.27B | -990.95M |
| Financing Cash Flow | 0 | -295.91M | 913.67M | -2.43B | -857.03M | -1.19B |
Kovai Medical Center & Hospital Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KOVAI, the sentiment is Positive. The current price of 6467.80 is above the 20-day moving average (MA) of 6080.48, above the 50-day MA of 6053.95, and above the 200-day MA of 5712.65, indicating a bullish trend. The MACD of 149.14 indicates Negative momentum. The RSI at 63.51 is Neutral, neither overbought nor oversold. The STOCH value of 74.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:KOVAI.
Kovai Medical Center & Hospital Ltd. Peers Comparison
Overall Rating
IN:YATHARTH80Outperform
IN:INDRAMEDCO77Outperform
IN:KOVAI76Outperform
IN:ARTEMISMED73Outperform
IN:JLHL72Outperform
IN:SHALBY43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | INR 104.14B | 54.55 | ― | 0.05% | 50.40% | 24.94% | |
| 77Outperform | INR 33.06B | 17.20 | ― | 1.11% | 10.72% | 9.95% | |
| 76Outperform | INR 70.77B | 26.14 | ― | 0.23% | 16.69% | 18.45% | |
| 73Outperform | INR 53.70B | 45.59 | ― | 0.13% | 14.77% | 8.40% | |
| 72Outperform | INR 92.05B | 49.51 | ― | 0.07% | 16.71% | -6.09% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 43Neutral | INR 13.20B | 33.95 | ― | ― | 7.27% | 774.36% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:KOVAI | Kovai Medical Center & Hospital Ltd. | 6467.80 | 496.07 | 8.31% | |
| IN:ARTEMISMED | Artemis Medicare Services Ltd. | 339.20 | 60.97 | 21.91% | |
| IN:INDRAMEDCO | Indraprastha Medical Corporation Limited | 360.65 | -150.81 | -29.49% | |
| IN:JLHL | Jupiter Life Line Hospitals Ltd. | 280.80 | -6.83 | -2.37% | |
| IN:SHALBY | Shalby Ltd. | 122.25 | -94.95 | -43.72% | |
| IN:YATHARTH | Yatharth Hospital and Trauma Care Services Limited | 1080.80 | 319.90 | 42.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 15, 2026
